The state’s Medicaid program will receive a nice little chunk of change out of a $50.7 million settlement by Arkansas, other states and the federal government with two pharmaceutical companies.
Slightly more than $63,000 will be making its way into the state’s Medicaid line item after allegations that Novo Nordisk Inc., and UCB Inc., untruthfully marketed their products resulting in numerous false Medicaid claims, according to Arkansas News.
The allocation comes on the heels of another pharmaceutical settlement with Eli Lilly in which the lion’s share of $18.5 million — excepting the $500,000 to set up a cyber crimes unit — was also appropriated into the state Medicaid fund.
Loading ...